Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28265222 | 0.93 | SLC6A4 (0.51) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL13166017 | 0.89 | SLC6A4 (0.58) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL13166015 | 0.89 | SLC6A4 (0.58) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL20172543 | 0.89 | SLC6A4 (0.58) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL28701941 | 0.83 | BDKRB2 (0.39) | SLC6A4 | |
| SCHEMBL28296170 | 0.82 | SLC6A4 (0.69) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL13623704 | 0.81 | SLC6A4 (0.62) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL6017470 | 0.81 | SLC6A4 (0.62) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL27898395 | 0.81 | TDP1 (0.49) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA | |
| SCHEMBL27665009 | 0.81 | SLC6A4 (0.49) | SLC6A4CYP1A2CYP2D6CYP2C19LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7987539-B2 | mixture 1H-Benzimidazole, 2-(4-Thiazolyl) with soap, builder, peroxide, bleach activator, hydrotropic agent, softener; treatment of hard surfaces and textile fibre materials; protection from oder, discoloration, Chaetomium globosum, geosmin; all-purpose cleaners; fungi and dust mites growth control | BASF SE Ludwigshafen (DE) | 2011-08-02 | — | — | US | disclosed |
| US-7700078-B2 | Stabilization of body-care and household products | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| US-7452854-B2 | Aqueous fabric softener formulations comprising copolymers of cationic acrylates and N-alkyl acrylamides | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-11-18 | — | — | US | disclosed |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-11-13 | — | — | US | disclosed |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-10-23 | — | — | US | disclosed |
| US-7423006-B2 | Aqueous cleaning compositions comprising cationic copolymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-09-09 | — | — | US | disclosed |
| US-7410940-B2 | Antioxidants for the stabilization of surfactant formulations | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-08-12 | — | — | US | disclosed |
| US-20080108540-A1 | Antioxidants for the stabilization of formulations comprising surfactants | HUEGLIN DIETMAR | 2008-05-08 | — | — | US | disclosed |
| US-20080058393-A1 | Fungicidal Detergent Compositions | BASF SE (DE) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058393-A1 | Fungicidal Detergent Compositions | C9, C5, C1S | SLC6A4 4621/4885CYP1A2 118/4885CYP2D6 368/4885 |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | SLC6A4 2772/4885CYP1A2 77/4885CYP2D6 308/4885 |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | SLC6A4 2772/4885CYP1A2 77/4885CYP2D6 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.